|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2170959 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08768485.8 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-02 |
| (46) | Date of publication of the claims translation | 2014-01-27 |
| (86) | Number | PCT/US2008/007463 |
| Date | 2008-06-13 |
| (87) | Number | WO 2008/156712 |
| Date | 2008-12-24 |
| (30) | Number | Date | Country code |
| 944583 P | 2007-06-18 | US |
| (72) |
CARVEN, Gregory John, US
VAN EENENNAAM, Hans, NL
DULOS, Gradus Johannes, NL
|
| (73) |
Merck Sharp & Dohme B.V.,
Waarderweg 39, 2031 BN Haarlem,
NL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai prieš žmogaus užprogramuotą mirties receptorių PD-1 |
| ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 |
| Payment date | Validity (years) | Amount | |
| 2025-05-09 | 18 | 347.00 EUR |
| 2026-06-13 |